Oct 21 2015 webinar COMBINED PRESENTATION SLIDES...
Transcript of Oct 21 2015 webinar COMBINED PRESENTATION SLIDES...
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 1
2015 Pharmacy Education Series
October 21, 2015Control Substance Drug Diversion:g
What Keeps Us Up at Night and Closing the Gaps to Get a Full Night Sleep
Featured Speakers:
James Arnold Christopher R. Fortier, PharmD, FASHPChief of Regulatory Policy Chief Pharmacy OfficerOffice of Diversion Control Massachusetts General HospitalDrug Enforcement Administration
1
Submission of an online evaluation is the only way to obtain CE credit
Online Evaluation, Self-Assessmentand CE Credit
Submission of an online evaluation is the only way to obtain CE credit for this webinar
Go to www.ProCE.com/CHSRx Webinar attendees will also receive an email with a direct link to the
web page Print your CE statement of completion online
– Credit for live or enduring only
Deadline: November 20, 2015( l bl h )
2
CPE Monitor (applicable to pharmacists)– CE information automatically uploaded to NABP/CPE Monitor within 1 to 2
weeks of the completion of the self‐assessment and evaluation
Event Code
Code will be provided at the end of today’s activity
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 2
How to Ask a Question
Locate menu bar on your computer desktop Click No!
Click orange arrow button
Menu box will open
Type question into question box
Click Send
Do not close menu box
– This will disconnect you from the Webcast
Please submit questions throughout presentation
Enter question
Click Send
3
Accessing PDF Handout
Click the hyperlink that is located directly above the No!located directly above the question box
Do not close menu box
– This will disconnect you
from the Webcast
Close other applications Clickhyperlinkhyperlink
4
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 3
October 21, 2015Control Substance Drug Diversion:
What Keeps Us Up at Night and Closing the Gaps to Get a Full Night Sleep
Featured Speakers:
James Arnold Christopher R. Fortier, PharmD, FASHPChief of Regulatory Policy Chief Pharmacy OfficerChief of Regulatory Policy Office of Diversion Control Massachusetts General Hospital
5
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Mr. Arnold has no relevant commercial and/or financial relationships to disclose. Dr. Fortier has no relevant commercial and/or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Chief of Regulatory Policy, Office of Diversion Control Massachusetts General HospitalDrug Enforcement Administration
CE Activity Information & Accreditation
ProCE, Inc. (Pharmacist CE)
– 2.0 contact hours
F di
6
Funding:This activity is self‐funded through CHSPSC.
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 4
Diversion Prevention in Hospitals for Diversion Prevention in Hospitals for Hospital PharmacistsHospital Pharmacists
October 21, 2015October 21, 2015
James “Jim” ArnoldChief/PolicyDEA Headquarters 202-353-1414 7
The mission of the Office of Diversion Control is to prevent, detect, and investigateth di i f h ti l t ll dthe diversion of pharmaceutical controlled substances (CS) and listed chemicals from legitimate channels of distribution
while …ensuring an adequate and uninterrupted supply of controlled substances to meet legitimate medical, commercial, andscientific needs
8
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 5
Foreign Mfr Importer Manufacturer
Distri-butor
?
PractitionerPharmacyHospitalClinic
9
The movement of legitimate controlled substances into other than legitimate channelssubstances into other than legitimate channels for other than legitimate medical, scientific, and/or research needs.
10
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 6
Anytime Anyplace Under AnyAnytime, Anyplace, Under AnyCircumstances, with Anyone
11
“Traveler Nurse Who Worked in NHF Maine Suspended”
“Suspended nurse charged with drug possession Nurse accused of trying to divert controlled drugs”
“Portsmouth nurse suspended for alleged fentanyl diversion”
“Ml: Doctor nearly dies of overdose with drugs stolen from hospital”
12
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 7
“Three Men Indicted On Charges Of Stealing Drugs From Walter Reed And Fort Belvoir Hospitals”
“New York Methodist Hospital Agrees To ImplementCompliance Program, To Settle Civil Claims Under The Controlled Substances Act. Hospital's Residents Issued Improper Prescriptions For Adderall, A HighlyAddictive Stimulant”
“Dignity Health Agrees To Pay $1.55 Million In Civil Penalties To Resolve Controlled Substances Act Claims”
13
“Mass. General Will Pay $2.3M To Settle DrugViolations”
“Doctors, medical staff on drugs put patients at risk”
“Former Employee of Exeter Hospital Sentenced to 39 Years in Connection with Widespread Hepatitis CO tbreak”Outbreak”
14
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 8
“The Human Factor”
15
Physicians
Interns
Residents
Pharmacists
Pharmacy Technicians
Physician Assistants
Nurses
Orderlies
Other Employees (e.g. Janitors, Administrative Staff, Contractors, Electricians, General Maintenance Personnel, Volunteers)
Visitors 16
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 9
Hydrocodone2 248 000 333 D U i
Oxycodone
Comparison of Comparison of ARCOS ARCOS Reported Reported HospitalHospital PurchasesPurchases
January 1, 2010 January 1, 2010 –– June 30, 2015June 30, 2015
2,248,000,333 Dosage Units2,358,423,526 Dosage Units
36% 34%
9%21%
Remaining 21 Drugs1,349,135,380 Dosage Units
Morphine577,400,062 Dosage Units
Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis UnitSource: ARCOS
Date Prepared: 10/14/2015
17
Hydrocodone5,135 TheftsOxycodone
Comparison of Comparison of Hospital Hospital Reported Reported TheftsThefts NationwideNationwide
January 1, 2010 January 1, 2010 –– September 30, 2015September 30, 2015(All Theft (All Theft Categories IncludedCategories Included))
5,135 Thefts6,407 Thefts
20% 16%
14%
13%8%4%
25%
Morphine4,380 Thefts
Hydromorphone8%4%
Fentanyl2,597 Thefts
Lorazepam1,432 Thefts
Remaining 56 Drugs8,146 Thefts
4,305 Thefts
Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis UnitSource: ARCOS
Date Prepared: 10/14/2015
18
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 10
ADS Machines (Pyxis Machines)Emergency RoomsMedication CartsMedication CartsNursing Station (CS Holding/Staging Areas)Operating RoomPatient, Patient Rooms, Patient Personal MedicationsPatient Controlled Analgesia (PCA)PharmacyWaste Disposal Areas
19
PYXIS Reports
Can be run/sorted by different variables
Typical sort is to run all CII‐CIV and all patients by user
Information obtained can be reformattedcan be reformatted later
20
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 11
PYXIS Record
Automated MAR/Surgery Record
21
22
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 12
21 CFR § 1301.71(a) § ( )
“All applicants and registrants shall provide effective controls and procedures to guard against theft and diversion of controlled substances.”
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
23
21 CFR § 1306.04(a)
A prescription for a controlledA prescription for a controlled substance to be effective must be issued for a legitimatemedical purpose by an individual practitioner acting in the usual course of histhe usual course of his professional practice.
United States v Moore 423 US 122 (1975)
24
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 13
21 CFR § 1306.04(a)
The responsibility for theThe responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests withresponsibility rests with the pharmacist who fills the prescription.
25
• A pharmacist, by law, has a corresponding responsibility to ensure that prescriptionsresponsibility to ensure that prescriptions are legitimate
• Just because a prescription is presented by a patient or demanded to be filled for a patient by a doctor’s office a pharmacist ispatient by a doctor’s office, a pharmacist is not obligated to fill the prescription!!!
26
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 14
Suggested Preventative MeasuresSuggested Preventative Measures
• Pre‐Employment Screening– Background Checksg
– Drug Screening
• Updated Background Checks Every Five Years
• Random Drug Screening
• Physical Security Controls
• SOP’s for Handling Controlled Substances
• Limited Access to Controlled Substances
• Limited Access to Alarms, Keys, Pass Codes
27
Suggested Preventative MeasuresSuggested Preventative Measures
• Limited Access to Dispensing Areas• At Least Two employees at all timesp y• Cameras in all areas where CS are being dispensed
• Secure access to CS ordering systems (CSOS) • Do not post the password for ordering CS electronically on the wall of the pharmacy
• Limited Power of Attorney status for signing DEA 222 order forms
• Tell Physicians to secure their prescription pads
28
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 15
www.deadiversion.usdoj.gov
DEA WebDEA Web‐‐Based ResourcesBased Resources
29
Thank You / Questions Thank You / Questions
30
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 16
CONTROL SUBSTANCE DRUG DIVERSION: WHAT KEEPS US UP ATDIVERSION: WHAT KEEPS US UP AT NIGHT AND CLOSING THE GAPS TO
GET A FULL NIGHT SLEEP
Ch i t h F ti Ph D FASHPChristopher Fortier, PharmD, FASHPChief Pharmacy Officer
Massachusetts General HospitalBoston, MA
September 30, 2015
31
32
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 17
STATISTICS
100,000 annually
1 in10
76 million to 210 million76 million to 210 million
5 million to 45 million33
OBJECTIVES
• Describe a hospital’s experience around control substance drug diversion and a regulatory agency’ssubstance drug diversion and a regulatory agency s internal investigation
• Discuss the specific drug diversion process improvement initiatives, policy development, and optimization between pharmacy, nursing, anesthesia and hospital security
• Outline the lessons learned and potential system gaps• Outline the lessons learned and potential system gaps when implementing a comprehensive diversion surveillance program and consistent compliance around regulatory reporting requirements
Speaker has no conflicts of interest to disclose 34
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 18
Title 54 pt Arial, Two Line Maximum
24 pt Arial Italic Subtitle, Presenter N / D tName/ Date
HOSPITALMASS GENERAL
35
MASS GENERAL HOPITAL
• 1,000 bed academic medical center and clinics across Boston‐metro area
• 1.9 million control substances dispensed annually– 2.3 ADM control substance transactions annually
• 30,000 employees
– 2,400 physicians
– 380 pharmacy employees
– 3,800 nurses
– 450 anesthesia providers
• Automation
– 190 automated dispensing machines
– 85 anesthesia workstations
36
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 19
THEBASICS 37
QUESTION• If the DEA issues a warrant at your
institution today could you provide them with 2 years worth of usable controlwith 2 years worth of usable control substance records?
• 1304.04 Maintenance of records and inventories.
Every inventory and other records required to be kept under this part must b k t b th i t t d bbe kept by the registrant and be available, for at least 2 years from the date of such inventory or records, for inspection and copying by authorized employees of the Administration.
38
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 20
QUESTION• Are you matching your CSOS orders to your
invoices electronically?
• 1311.60 Recordkeeping.
(a) A supplier and purchaser must maintain records of CSOS electronic orders and any linked records for two years. Records may be maintained electronically. Records regarding controlled substances that are maintained electronically must be readily retrievable fromelectronically must be readily retrievable from all other records.
(b) Electronic records must be easily readable or easily rendered into a format that a person can read. They must be made available to the
Administration upon request.39
THE BASICS
• 2‐years readily retrievable data
• Files– CSOS order/invoice matchingdata
• DEA binder– Hospital licensed sites
– Biennial inventory
– Power of Attorney forms
– DEA/DPH licenses
– Suspicious monitoring
CSOS order/invoice matching
– DEA 222 forms
– Reverse distributor
– Weekly narcotic inventories
• Narcotic vault– Limited access and hours
• Process to remove – Inventory integrity
– BAA
– DEA 106 filings
employees from system
• Nationally certified techs
40
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 21
THE BASICS
• Biennial inventory • Control substance li d t b fil– Open or close of
business
– Ideally all on same day
– Physical inventory
– Pharmacist/tech sign off
– Kits expired drug
online database files
– DPH and DEA filing
– Investigation documents
– Associated safety reports
Kits, expired drug, quarantined items
41
• Task force
A-TEAMTHE
42
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 22
DRUG DIVERSION TASK FORCE
Executive Sponsor: SVP Administration
Sr. Director Control Substance Compliance
&Surveillance
Executive Sponsor: SVP Patient Care
Nursing Quality & Safety Director &
Staff
Associate Chief Nurse & Staff
Police & Security Director & Staff
Chief Pharmacy Officer & Staff
Chief Compliance Officer & Staff
43
• education
44
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 23
STAFF EDUCATION• Pharmacy, nursing, anesthesia
A l d t t i i– Annual mandatory training
• Signs and symptoms
• Nurse training
– Phase I – Wasting, disposal, returning
Phase II Control substance electronic– Phase II – Control substance electronic surveillance training
– Phase III – Best practices/discrepancy
– Phase IV – Override list changes
45
STAFF EDUCATIONWasting complete doses Removal under someone else
Withdrawing without an order Giving less than what was ordered
Dropping/breaking containers Canceled transactions
Removal for discharged patient Duplicative doses
Withdrawing for patient who do need pain meds
Asks a colleague to witness a waste that has already been wasted
Volunteers for overtime often Frequent trips to bathroom
Willing to float or stay late often Long trips off unit
Comes into work when not assigned or scheduled
Discrepancies between patient reports of pain relief and charted meds
Readily volunteers to medicate other patients Consistently signing out maximum amount of narcotics
Volunteers to waste medication that was not administered by him/her 46
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 24
Fotolia_50770216_1040.jpg
• surveillance
SURVEILLANCE
47
QUESTION• What does the DEA statutes say around what ansay around what an institution should be doing around monitoring surveillance reports?
48
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 25
ORGANIZATIONAL DASHBOARDNursing Measures
Anomalous User and User Activity Checks. (Daily)
Activity and User Checks (S‐S‐H)
Shift Discrepancy Checksp y
Pharmacy / Anesthesia Measures
Post Case Reconciliation Compliance (Daily)
Pharmacy Measures
DEA 106 Filings
Destock‐Null Transactions (Daily)
Destock‐Null Transactions (Weekly)
Discrepancy Checks (Daily)
Dispense >5 Report (Daily)
DPH Filingsg
Global List Transaction Review (Weekly)
Inventory Integrity Checks‐ Endoscopy (Monthly)
Override Report (Daily)
Suspicious Order Monitoring (Monthly)
Terminated Employee ADM Removal (Monthly)
Annual Inventory
Site Visits
49
NURSE DISCREPANCY CHECK
Two nurses complete discrepancy check at
change of shiftDiscrepancy identified
Nurses check ADM Transaction by item
report
and complete review
Discrepancy not resolved....
Immediately call Pharmacy & notify
nurse director and/or clinical nursingclinical nursing supervisor
50
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 26
ANOMALOUS USAGE REPORT
51
ADM OVERRIDE REPORTomni_stid xact_dati pat_id MRN pat_name item_id rx_name qty_rem user_name Compliant? Comments Resolution
MGBLA12L 09‐07‐14 06:36 *011025770 Smith, John 8268800morPHINE
4MG/1ML 1ML 3 RN yMGBLA12L 09 07 14 06:36 011025770 Smith, John 8268800 4MG/1ML 1ML TUBEX
3 RN y
MGBLA12L 09‐07‐14 11:00 *011025770 Smith, John 8268800morPHINE
4MG/1ML 1ML TUBEX
2 RN n No Med OrderDrug Returned to Omnicell
MGELL04L 09‐07‐14 16:15 ***146579 Doe, Jane 8459200Oxycodone
5MG/5ML 5ML SOLUT
2 RN y
MGELL07L 09‐07‐14 03:40 ***1378851 Richard, Richard 8268800morPHINE
4MG/1ML 1ML TUBEX
1 RN y
MGELL09 09‐07‐14 10:11 ****391572 Shine, Sun 8171000Lorazepam
2MG/1ML 1ML VIAL
1 RN y
MGELL09 09‐07‐14 15:30 ***1008642 Bright, Star 8262600morPHINE
2MG/1ML 1ML TUBEX
1 RN y
MGELL14B 09‐07‐14 13:40 ****391646 Stein, Frank N. 8268800morPHINE
4MG/1ML 1ML TUBEX
1 RN y
52
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 27
GREATER THAN 5G143041390583 NAME
March 17, 2015 12:22 AM METHADONE ORAL SOLN 5MG/5ML QTY: 13.00
March 17, 2015 9:13 AM METHADONE ORAL SOLN 5MG/5ML QTY: 13.00
March 17, 2015 3:38 PM METHADONE ORAL SOLN 5MG/5ML QTY: 13.00
March 17, 2015 11:16 PM METHADONE ORAL SOLN 5MG/5ML QTY: 13.00
L083041861194 NAME
March 17, 2015 6:12 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
March 17, 2015 7:05 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
March 17, 2015 7:49 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
March 17, 2015 9:41 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
March 17, 2015 10:45 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
March 17, 2015 11:39 PM hydroMORPHone 2MG/ML 1ML SYRINGE QTY: 6.00
L093041616118 NAME
March 17, 2015 9:17 PM OXYCODONE 5MG TABLET QTY: 8.00
L103031615396 NAME
March 17, 2015 6:03 AM OXYCODONE IMMED RELEASE 20 MG TAB QTY: 6.00
March 17, 2015 9:27 AM OXYCODONE IMMED RELEASE 20 MG TAB QTY: 6.00
March 17, 2015 11:53 AM OXYCODONE IMMED RELEASE 20 MG TAB QTY: 6.00
3041430347 NAME
March 17, 2015 12:38 AM OXYCODONE 5MG TABLET QTY: 6.00
March 17, 2015 4:33 AM OXYCODONE 5MG TABLET QTY: 6.00
March 17, 2015 8:31 AM OXYCODONE 5MG TABLET QTY: 6.00
53
OPERATING ROOM• Highest area/providers of risk
Kit b– Kits, bags
– Drug waste
• Anesthesia workstations/biometrics
• Post‐case reconciliation
• Trend analysis• Trend analysis
54
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 28
OR POST-CASE RECONCILIATIONPost‐Case Reconciliation ‐ Monthly Compliance Trending (Sorted by Incident)
"Y" = PCR was Compliant 2014‐09 2014‐10 2014‐11 2014‐12 2015‐01 2015‐02 6 Months
user_name y n % y n % y n % y n % y n % y n % y n %
Gelineau, Amanda Maria 50 100.0% 136 5 96.5% 9 100.0% ‐ ‐ ‐ 82 100.0% 107 100.0% 384 5 98.7%
Spencer, Rebecca 47 100.0% 53 5 91.4% 62 100.0% 29 100.0% ‐ ‐ ‐ ‐ ‐ ‐ 191 5 97.4%
Greenberg, Deborah ‐ ‐ ‐ 2 4 33.3% 7 100.0% 6 100.0% 6 100.0% 7 1 87.5% 28 5 84.8%
Levine, Amy 2 100.0% 2 4 33.3% 4 100.0% ‐ ‐ ‐ 4 100.0% ‐ ‐ ‐ 12 4 75.0%
Lighthall, Samantha 2 0.0% 2 100.0% 2 100.0% 6 100.0% ‐ ‐ ‐ 2 2 50.0% 12 4 75.0%
Holley, Catherine 2 4 33.3% ‐ ‐ ‐ ‐ ‐ ‐ 2 100.0% 2 100.0% ‐ ‐ ‐ 6 4 60.0%
Gao, Lei 50 100.0% 96 3 97.0% 126 100.0% 86 100.0% 24 100.0% 86 100.0% 468 3 99.4%
Walsh, Tomas ‐ ‐ ‐ 58 3 95.1% 7 100.0% 48 100.0% 2 100.0% 103 100.0% 218 3 98.6%
Sayal, Puneet ‐ ‐ ‐ 22 3 88.0% ‐ ‐ ‐ 25 100.0% 36 100.0% ‐ ‐ ‐ 83 3 96.5%
Bartels, David DB#2046 ‐ ‐ ‐ 41 2 95.3% 111 100.0% 111 100.0% 90 100.0% ‐ ‐ ‐ 353 2 99.4%
Norato, Christine 15 100.0% 40 2 95.2% 30 100.0% 75 100.0% 82 100.0% 80 100.0% 322 2 99.4%
Yelle,Marc 40 100.0% 63 2 96.9% ‐ ‐ ‐ 5 100.0% 9 100.0% 74 100.0% 191 2 99.0%
Kim, Peggy 1890 ‐ ‐ ‐ ‐ ‐ ‐ 46 100.0% 12 2 85.7% 61 100.0% ‐ ‐ ‐ 119 2 98.3%
Cox, Jessica #1975 16 100.0% ‐ ‐ ‐ 9 2 81.8% ‐ ‐ ‐ 54 100.0% 36 100.0% 115 2 98.3%
Vanneman, Matthew 60 100.0% 111 1 99.1% 100 100.0% 146 100.0% 6 100.0% 127 100.0% 550 1 99.8%
Safavi, Kyan DB#2044 ‐ ‐ ‐ 97 1 99.0% 141 100.0% 117 100.0% 78 100.0% 115 100.0% 548 1 99.8%
Dougherty, Kelly 16 100.0% 58 1 98.3% 56 100.0% 65 100.0% 62 100.0% 93 100.0% 350 1 99.7%
55
AMBULATORY CLINICS• Non‐profiled or paper
bl• Tabletop ADM
• Records kept on site
– 222 paperwork
– Biennial inventory
Power of attorney– Power of attorney
• Camera surveillance
56
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 29
http://premium.wpmudev.org/blog/wp-content/uploads/2012/07/user-
logging-lineup jpg• investigation
logging lineup.jpg
INVESTIGATION 57
QUESTION• Do you have a formal multidisciplinary drug
diversion investigations team at your institution?
• 1301.92 Illicit activities by employees.It is the position of DEA that employees who possess, sell, use or divert controlled substances will subject themselves not only to State or Federal prosecution for any illicit activity, but shall also immediately become the subject of independent action regarding their continued employment. The employer ill th i f th l 'will assess the seriousness of the employee's
violation, the position of responsibility held by the employee, past record of employment, etc., in determining whether to suspend, transfer, terminate or take other action against the employee.
58
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 30
INVESTIGATION
• DDTF Special Task Force
– Pharmacy, nursing, police & security, occupational health, HR, employee assistance
• Data collection time period
– 3‐6 months, 1‐2 years
• Police & Security interviewPolice & Security interview
• Drug screen
Removed from Omnicell
Documented in eMAR Wasted Waste Comments
MRN Patient Name Medication Date Time AmountOverrid
e Date Time Amount Date Time Amount Witness
59
• reporting
REPORTING60
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 31
QUESTION• What is the minimum drug quantity loss that
requires an institution to file a DEA 106?• 1301.76 Other security controls for practitioners.y p
(b) The registrant shall notify the Field Division Office of the Administration in his area, in writing, of the theft or significant loss of any controlled substances within one business day of discovery of such loss or theft. The registrant shall also complete, and submit to the Field Division Office in his area, DEA Form 106 regarding the loss or theft. When determining whether a loss is significant, a registrant should consider, among others, the following factors:(3) Whether the loss of the controlled substances can be associated with access to those controlled substances by specific individuals, or whether the loss can be attributed to unique activities that may take place involving the controlled substances;substances;(4) A pattern of losses over a specific time period, whether the losses appear to be random, and the results of efforts taken to resolve the losses; and, if known,(5) Whether the specific controlled substances are likely candidates for diversion;(6) Local trends and other indicators of the diversion potential of the missing controlled substance.
61
REPORTING• Utilize organizational safety report system to file loss
Rule of Thumb: < or >5– Rule of Thumb: < or >5
• Regulatory filings– DPH within 7 days (<5) – Massachusetts regulation– DEA 106 with 24 hours (>5)– Addendums within 45 days
• Will document what disciplinary action took place
• Other agenciesOther agencies– BOP, DPH, CMS, FDA, Board of Nursing, Board of Medical Practice
62
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 32
http://cx.aos.ask.com/question/aq/700px-700px/far-back-can-irs-audit 30c97076e46eeec2 jpgaudit_30c97076e46eeec2.jpg
AUDITING 63
AUDIT• Trending reports
– Event type, medication, location, user
– Post‐case reconciliation
– Employee volume comparisons
• Accountability audits
– 6 selected drug by independent auditor annually
• On‐site record audits of all DEA licenses
– Biennial inventory, powers of attorney, 222 forms, DEA 106’s, invoices
• Pharmacy employees• Pharmacy employees
– Null transactions, destock, overrides
• Suspicious monitoring
• Inventory integrity
64
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 33
REPORT TRENDING
10
11
13
FENTANYL
FENTANYL 50 MCG/ ML
FENTANYL 50 MCG/ ML
40
2
3
3
4
5
6
6
6
10
DILAUDID (HYDROMORPHONE HCL)
MORPHINE SULFATE
(blank)
ATIVAN (LORAZEPAM)
MIDAZOLAM
OXYCODONE
METHADONE
LORAZEPAM
ren
d C
ate
go
ry
12
32
14
18
15
20
25
30
35
Number of Submissions
20
2
2
2
2
2
0 5 10 15 20 25
Individually Reported Medications
VERSED (MIDAZOLAM)
PREGABALIN
FENTANYL 50 MCG/ ML; VERSED (MIDAZOLAM)
FENTANYL (PATCH)
( )
Tr
5 54
10 10
1
0
5
10
2014‐01 2014‐02 2014‐03 2014‐04 2014‐05 2014‐06 2014‐07 2014‐08 2014‐09 2014‐10
N
Month of Submittal
65
• technology
TECHNOLOGY 66
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 34
AUTOMATION/TECHNOLOGY
• Understanding how technology works/limitationsworks/limitations
– ADM, anesthesia workstation, surveillance systems, pharmacy CS inventory system
– e.g. When patients are discharged from system
• System configurations
• Upgrades/system enhancements
• Access to quick and usable data
– 2 years worth of readily retrievable data67
http://fullhdwp.com/images/wallpapers/Bank_Vault_3D_Wallpaper-
HD jpghttp://fullhdwp com/images/• Pharmacy totesHD.jpghttp://fullhdwp.com/images/wallpapers/Bank_Vault_3D_Wallpa
per-HD.jpg
PHARMACYCONTROL 68
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 35
ORDERING, RECEIVING, STORAGE, RETURNING
• Ordering– Different than person
• Storage– Patients own meds
receiving– Limited to certain
employees/POA
• Receiving– Totes immediately to vault
and processed– CSOS matching
– Cameras– Biometrics– Override list– Profile vs. non‐profiled– Downtime procedures
• Returning– Return bins– Limiting vault and staff
access
• Distribution– Limited daily pulls– Locked delivery cabinets
– Return bins– Drug waste– Reverse distributors
69
COLLECTING UNUSED CONTROLS
• DEA rule went into effect October 9, 2014• 1317.75 Collection receptacles.
(b). Controlled and non‐controlled substances may be collected together and be comingled, although comingling is not required.(c) Collectors shall only allow ultimate users and other authorized non‐registrant persons in lawful possession of a controlled substance in Schedule II, III, IV, or V to deposit such substances in a collection receptacle at a registered location. Once a substance has been deposited into a collection receptacle, the substance shall not be counted, sorted, inventoried, or otherwise individually handled.(d) Collection receptacles shall be securely placed and maintained:(2) At a registered location, be located in the immediate proximity of a designated area where controlled substances are stored and at which an employee is present (e.g., can be p y p ( g ,seen from the pharmacy counter)..(g) The installation and removal of the inner liner of the collection receptacle shall be performed by or under the supervision of at least two employees of the authorized collector.
70
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 36
OTHER AREAS OF CONSIDERATION
• Human resources
– Drug testing?– Drug testing?
• Non‐clinical hospital employees
• Waste containers
– Syringe with drug waste, liquid
• Compounding
• Research
• Policies
• Non‐pharmacy DEA licenses
71
LESSONSLEARNED 72
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 37
DEA SETTLEMENTS• California‐ 2014
– Settlement: $1.55 million to resolve claims it mishandled control substances
– Violations:– Violations: • Theft of between 20, 000 – 30,000 hydrocodone tablets from its outpatient pharmacy in 2010 and 2011.
• Numerous recordkeeping errors, such as missing signatures on delivery slips and inventory adjustments, as well as missing invoices.
• Oklahoma ‐ 2011– Settlement: $1,000,000,
– Violations:• Inconsistencies in narcotic inventories resulting from pharmacy transfers to Surgical center.
• Disclosed discrepancies to Board of Pharmacy and DEA.
• Distributed methadone to medical facility not registered
• Failed to maintain proper methadone records and inventoriesFailed to maintain proper methadone records and inventories.
• Indiana ‐ 2007 – Settlement: $2 million
– Violations:• Investigation began based on allegations a pharmacy tech was stealing hydrocodone.
• DEA discovered that the hospital was unable to account for 623,843 hydrocodone tablets.
• Failed to keep accurate records and make accurate reports designed to safeguard the public against diversion.
73
LESSONS LEARNED• Are you looking hard enough?
l idi i li ll b i i i i l• Multidisciplinary collaboration is critical
• Variety of surveillance and audit tools
• Resources dedicated to sustaining program
• Program visibility is major deterrent
74
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 38
Questions?
Chris Fortier
75
U d t C tU d t C t PhPhUpdate on Current Update on Current Pharmacy Pharmacy Initiatives and StrategiesInitiatives and Strategies
77
Robert Fink, Pharm.D., M.B.A., FASHP, FACHE, BCNSP, BCPS
Chief Pharmacy Executive
Community Health Systems
Control Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night SleepCHS Pharmacy Education Series
ProCE, Inc.www.ProCE.com 39
78